Temocapril, an angiotensin converting enzyme inhibitor, protects against diabetes-induced endothelial dysfunction

European Journal of Pharmacology

Volumn 403, Issue 1-2, 2000, Pages 129-132

  Pieper, Galen M ^a   Siebeneich, Wolfgang ^a  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

Author keywords

Angiotensin; Diabetes mellitus; Endothelium; Nitric oxide (NO)

Indexed keywords

ACETYLCHOLINE; GLUCOSE; GLYCERYL TRINITRATE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; TEMOCAPRIL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; DIABETIC ANGIOPATHY; GLUCOSE BLOOD LEVEL; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; VASODILATATION;

ACETYLCHOLINE; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANIMALS; AORTA, THORACIC; BLOOD GLUCOSE; DIABETES MELLITUS, EXPERIMENTAL; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOTHELIUM, VASCULAR; MALE; NOREPINEPHRINE; RATS; RATS, SPRAGUE-DAWLEY; THIAZEPINES; VASOCONSTRICTION; VASOCONSTRICTOR AGENTS; VASODILATION;

EID: 0034284398     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(00)00508-2     Document Type: Article

References (20)

1. Cohen R.A. Dysfunction of vascular endothelium in diabetes mellitus. Circulation. 87(suppl. V):1993;V67-76.
2. Finta K., Fisher M., Lee L., Gordon D., Pitt B., Webb R.C. Ramipril prevents impaired endothelium-dependent relaxation in arteries from rabbits fed an atherogenic diet. Atherosclerosis. 100:1993;149-156.
3. Fortes Z.B., Hyslop S., de Nucci G. Endothelium-derived vasoactive factors in the microcirculation: responsiveness to nitric oxide and endothelin in normal and diabetic states. Immunopharmacol. Microcirc. 3:1994;5-62.
4. Furuta S., Kiyosawa K., Higuchi M., Kasahara H., Saito H., Shioya H., Oguchi H. Pharmacokinetics of temocapril an ACE inhibitor with preferential biliary excretion in patients with impaired liver function. Eur. J. Clin. Pharmacol. 44:1993;383-385.
5. Goyal R.K., Satia M.C., Bangaru R.A., Gandhi T.P. Effect of long-term treatment with enalapril in streptozotocin diabetic and DOCA hypertensive rats. J. Cardiovasc. Pharmacol. 32:1998;317-322.
6. Kamata K., Miyata N., Abiru T., Kasuya Y. Functional changes in vascular smooth muscle and endothelium of arteries during diabetes mellitus. Life Sci. 50:1995;1379-1387.
7. Lammi-Keefe C.J., Swan P.B., Hegarty P.V.J. Evidence for increased peroxidative activity in muscles from streptozotocin-diabetic rats. Proc. Soc. Exp. Biol. Med. 176:1984;27-31.
8. Murray P., Pitt B., Webb R.C. Ramipril prevents hypersensitivity to phenylephrine in aorta from streptozotocin-induced diabetic rats. Diabetologia. 37:1994;664-670.
9. Olbrich A., Rösen P., Hilgers R.D., Dhein S. Fosinopril improves regulation of vascular tone in mesenteric bed of diabetic rats. J. Cardiovasc. Pharmacol. 27:1996;187-194.
10. O'Driscoll G., Green D., Rankin J., Stanton K., Taylor R. Improvement in endothelial function by angiotensin converting enzyme inhibition in insulin-dependent diabetes mellitus. J. Clin. Invest. 100:1997;678-684.
11. Pieper G.M. Review of alterations in endothelial nitric oxide production in diabetes: protective role of arginine on endothelial dysfunction. Hypertension. 31:1998;1047-1060.
12. Pieper G.M., Gross G.J. Endothelial dysfunction in diabetes. Rubanyi G.M. Cardiovascular Significance of Endothelium-Derived Vasoactive Factors. 1991;223-249 Futura Publising, Mount Kisco, NY.
13. Pieper G.M., Siebeneich W. Diabetes-induced endothelial dysfunction is prevented by chronic treatment with the modified iron chelator, hydroxyethyl starchconjugated deferoxamine. J. Cardiovasc. Pharmacol. 30:1997;734-738.
14. Pieper G.M., Siebeneich W. Oral administration of the antioxidant, N-acetylcysteine, abrogates diabetes-induced endothelial dysfunction. J. Cardiovasc. Pharmacol. 32:1998;101-105.
15. Pieper G.M., Mei D.A., Langenstroer P., O'Rourke S.T. Bioassay of endothelium-derived relaxing factor in diabetic rat aorta. Am. J. Physiol. (Heart Circ. Physiol.). 263(32):1992;H676-H680.
16. Pieper G.M., Siebeneich W., Roza A.M., Jordan M., Adams M.B. Chronic treatment in vivo with dimethylthiourea, a hydroxyl radical scavenger, prevents diabetes-induced endothelial dysfunction. J. Cardiovasc. Pharmacol. 28:1996;27-31.
17. Poston L., Taylor P.D. Endothelium-mediated vascular function in insulin-dependent diabetes mellitus. Clin. Sci. 88:1995;245-255.
18. Takemoto M., Egashira K., Tomita H., Usui M., Okamoto H., Kitabake A., Shimokawa H., Sueishi K., Takeshita A. Chronic angiotensin-converting enzyme inhibition and angiotensin II Type 1 receptor blockade. Effects on cardiovascular remodeling in rats induced by the long-term blockade of nitric oxide synthesis. Hypertension. 30:1997;1621-1627.
19. phox is a critical component of the superoxide-generating NADH/NADPH oxidase system and regulates angiotensin II-induced hypertrophy in vascular smooth muscle cells. J. Biol. Chem. 271:1996;23317-23321.
20. Wohaieb S.A., Godin D.V. Starvation-related alteration in free radical tissue defense mechanisms in rats. Diabetes. 36:1987;169-173.